We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
44 hedge funds and large institutions have $53.2M invested in Esperion Therapeutics in 2013 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,950% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 2
780% more funds holding
Funds holding: 5 → 44 (+39)
342% more capital invested
Capital invested by funds: $12M → $53.2M (+$41.1M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
44
Holders Change
+39
Holders Change %
+780%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$9.74M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.28M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$7.24M |
| 4 |
Morgan Stanley
New York
|
+$3.23M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.15M |
